Nowadays
people are suffering from involuntary loss of skeletal
In2020
sarcopenia is affecting 5 million individuals globally.
In 2050
500 million people will be diagnosed with sarcopenia
Future
Sarcopenia patients suffer from loss of autonomy and physical frailty.
Crisis
There is currently no specific drug for sarcopenia.
This year
team PTSH-Taiwan developed an engineered live biotherapeutic product with cocktail therapy to treat this multicausal disease
